Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPHEUS: Ticagrelor vs clopidogrel loading in elective PCI
2015-000850-39Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI), Myocardial injury and coronary arteriosclerosis comparing Ticagrelor loading (Brilique) with Clopidogrel loading (2 arms). Started Oct 2019; status: terminated.
02
Drugs
ticagrelorclopidogrel
03
Conditions
myocardial infarction (MI)Myocardial injurycoronary arteriosclerosis
Beyond the preview
Go deeper on 2015-000850-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000850-39.